Decreased cutaneous expression of stem cell factor and of the p75NGF receptor in urticaria

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 411-417

  Hermes, B ^a   Zuberbier, T ^b   Haas, N ^b   Henz, Beate M ^b  

^a Vivantes Klinikum Prenzlauer Berg   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

c Kit; Growth factors; Mast cells; Nerve growth factor; Stem cell factor; Urticaria

Indexed keywords

ALKALINE PHOSPHATASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P75; PROTEIN TYROSINE KINASE; RECEPTOR SUBTYPE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM; SKIN CELL; SKIN DEFECT; TISSUE SECTION; URTICARIA;

ENDOTHELIUM; EPIDERMIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; NERVE GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, NERVE GROWTH FACTOR; SKIN; STEM CELL FACTOR; URTICARIA;

EID: 0037364073     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05167.x     Document Type: Article

References (37)

1. Henz BM, Zuberbier T, Grabbe J, Monroe E. Urticaria - Clinical, Diagnostic and Therapeutic Aspects. Berlin: Springer, 1998.
2. Haas N, Toppe E, Henz BM. Microscopic morphology of different types of urticaria. Arch Dermatol 1998; 134: 41-6.
3. Natbony SF, Phillips ME, Elias JM et al. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983; 71: 177-83.
4. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77: 1033-79.
5. Welker P, Grabbe J, Zuberbier T, Henz BM. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral mononuclear cells. J Invest Dermatol 2000; 114: 44-50.
6. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994; 287: 78-84.
7. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994; 153: 3717-23.
8. Hartmann K, Henz BM, Krüger-Krasagakes S et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997; 89: 2863-70.
9. Costa JJ, Demetri GD, Harris TJ et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996; 183: 2681-6.
10. Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149: 599-608.
11. Welker P, Grabbe J, Grützkau A, Henz BM. Effects of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998; 94: 310-17.
12. Welker P, Grabbe J, Gibbs B, Henz BM. NCF induces mast cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000; 99: 418-26.
13. Henz BM, Hermes B, Welker P. Interactions between neurotrophins and mast cells. In: Mast Cells and Basophils in Physiology, Pathology and Host Defense (Marone G, Lichtenstein LM, Galli SJ, eds.). San Diego: Academic Press. 2000; 341-54.
14. Du Z, Li Y, Xia H et al. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. J Immunol 1997; 59: 838-45.
15. Welker P, Grabbe J, Zuberbier T, Henz BM. GM-CSF downregulates mast cell specific tryptase. FcεRI and histamine. Int Arch Allergy Appl Immunol 1997; 113: 284-6.
16. Welker P, Grabbe J, Zuberbier T et al. GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res 2001; 293: 249-58.
17. Gearing DP, King JA, Gough NM, Nicola NA. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 1989; 8: 3667-76.
18. Bussolini F, Wang JM, Defilippi P et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337: 471-3.
19. Kämpgen E, Koch F, Heufler C et al. Understanding the dendritic cell lineage through study of cytokine receptors. J Exp Med 1994; 179: 1767-76.
20. Hermes B, Welker P, Feldmann-Böddeker I et al. Expression of mast cell growth factors and their receptors in human scars. J Invest Dermatol 2001; 116: 387-93.
21. Hermes B, Prochazka A-K, Haas N et al. Upregulation of tumor necrosis factor α and interleukin-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999; 103: 307-14.
22. Krüger-Krasagakes S, Henz BM. Physical urticaria. In: Urticaria - Clinical, Diagnostic and Therapeutic Aspects (Henz BM, Zuberbier T, Grabbe J, Monroe E, eds). Berlin: Springer, 1998; 55-96.
23. Schadendorf D, Tiedemann K-H, Haas N, Czarnetzki BM. Detection of human papillomaviruses in paraffin-embedded condylomata acuminata. Comparison of immunohistochemistry, in situ hybridization and polymerase chain reaction. J Invest Dermatol 1991; 97: 549-54.
24. Dippel E, Haas N, Grabbe J et al. Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo. Br J Dermatol 1995; 132: 182-9.
25. Hermes B, Feldmann-Böddeker I. Welker P et al. Altered expression of mast cell tryptase and chymase and of c-kit in human cutaneous scar tissue. J Invest Dermatol 2000; 114: 51-5.
26. Welker P, Grabbe J, Henz BM. Human mast cells produce and differentially express soluble and membrane-bound stem cell factor. Scand J Immunol 1999; 49: 495-500.
27. Grabbe J, Welker P, Rosenbach T et al. Release of stem cell factor (SCF) from human keratinocytes (HaCaT) is increased in differentiating versus proliferating cells. J Invest Dermatol 1996; 107: 219-24.
28. Onuma H, Matsui C, Morokashi M. Enhanced expression of SCF in the dermis is a prognostic factor for the regression of urticaria pigmentosa. Eur J Dermatol 1999; 9: 629-32.
29. Longley BJ, Tyrrell L, Ma Y et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 1997; 94: 9017-21.
30. Smith CH, Kepley C, Schwartz LB, Lee TH. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995; 96: 360-4.
31. Barlow RJ, Ross EL, MacDonald DM et al. Mast cells and T lymphocytes in chronic urticaria. Clin Exp Allergy 1995; 25: 317-22.
32. Nilsson G, Forsberg-Nilsson K, Xiang Z et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27: 2295-301.
33. Bonini S, Lambiase A, Bonini S et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93: 10955-60.
34. Cartwright M, Mikheev AM, Heinrich G. Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic gene. Int J Dev Neurosci 1994; 12: 685-93.
35. Di Marco E, Marchisio PC, Bondanza S et al. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991; 266: 21718-22.
36. Artuc M, Hermes B, Steckelings UM et al. Mast cells and their mediators in cutaneous wound healing - active participants or innocent bystanders? Exp Dermatol 1999; 8: 1-16.
37. Tam SY, Tsai M, Yamaguchi M et al. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997; 90: 1807-20.